By investigating the p53 and pRb cross-talk and the role of RGS16 in pancreatic cancer cell migration, we have uncovered a novel regulator of metastatic processes that could be a future target in developing treatments to prevent the spread of pancreatic cancer. The gene discussed is RGS16; the disease is familial pancreatic carcinoma.